Target Name: MARVELD3
NCBI ID: G91862
Other Name(s): MRVLDC3 | MARVEL (membrane-associating) domain containing 3 | MARVEL domain-containing 3 | MALD3_HUMAN | MARVD3 | MARVEL domain-containing protein 3 | MARVEL domain containing 3, transcript variant 1 | MARVELD3 variant 1 | MARVEL domain containing 3 | MARVEL domain-containing protein 3 (isoform 1)

MarvelD3: A Potential Drug Target for Psychiatric Disorders

MarvelD3 (Mrvldc3) is a protein that is expressed in various tissues of the human body, including the brain, heart, and kidneys. It is a member of the tyrosine kinase family and is involved in the regulation of cellular processes that are essential for brain function, including neurotransmitter signaling and inflammation.

Recent studies have suggested that MarvelD3 may have potential as a drug target for a variety of diseases, including neurological and psychiatric disorders. Its role in these processes makes it an attractive target for researchers to explore for new treatments.

One of the key features of MarvelD3 is its ability to interact with other proteins that are involved in the regulation of cellular processes. This interaction allows MarvelD3 to regulate the activity of these proteins, which can have a wide range of effects on the cell.

One of the most promising aspects of MarvelD3 is its potential to treat psychiatric disorders. Studies have shown that MarvelD3 is involved in the regulation of the release of certain neurotransmitters, such as dopamine and serotonin, which are involved in mood and emotion.

Additionally, MarvelD3 has also been shown to play a role in the regulation of inflammation. Its ability to interact with other proteins involved in inflammation regulation makes it a potential target for treatments aimed at reducing inflammation and promoting anti-inflammatory effects.

Another potential application of MarvelD3 is its use as a cancer treatment. Studies have shown that MarvelD3 is involved in the regulation of cell proliferation and has the potential to inhibit the growth of cancer cells.

In addition to its potential as a drug target, MarvelD3 also has important implications for our understanding of brain development and plasticity. Its role in the regulation of cellular processes that are critical for brain development and function makes it an important molecule to study in the context of neuroscience.

Overall, MarvelD3 is a protein that has significant potential as a drug target and may be a valuable tool for the development of new treatments for a variety of psychiatric and neurological disorders. Further research is needed to fully understand its role and potential in these processes.

Protein Name: MARVEL Domain Containing 3

Functions: As a component of tight junctions, plays a role in paracellular ion conductivity

More Common Targets

MAS1 | MAS1L | MASP1 | MASP2 | MAST1 | MAST2 | MAST3 | MAST4 | MASTL | MAT1A | MAT2A | MAT2B | MATCAP1 | MATCAP2 | MATK | MATN1 | MATN1-AS1 | MATN2 | MATN3 | MATN4 | MATR3 | Matrix Metalloproteinase (MMP) | MAU2 | MAVS | MAX | MAZ | MB | MB21D2 | MBD1 | MBD2 | MBD2-MBD3 complex | MBD3 | MBD3L1 | MBD3L2 | MBD3L3 | MBD3L4 | MBD3L5 | MBD4 | MBD5 | MBD6 | MBIP | MBL1P | MBL2 | MBLAC1 | MBLAC2 | MBNL1 | MBNL1-AS1 | MBNL2 | MBNL3 | MBOAT1 | MBOAT2 | MBOAT4 | MBOAT7 | MBP | MBTD1 | MBTPS1 | MBTPS2 | MC1R | MC2R | MC3R | MC4R | MC5R | MCAM | MCAT | MCC | MCCC1 | MCCC2 | MCCD1 | MCCD1P1 | MCEE | MCEMP1 | MCF2 | MCF2L | MCF2L-AS1 | MCF2L2 | MCFD2 | MCFD2P1 | MCHR1 | MCHR2 | MCHR2-AS1 | MCIDAS | MCL1 | MCM10 | MCM2 | MCM3 | MCM3AP | MCM3AP-AS1 | MCM4 | MCM5 | MCM6 | MCM7 | MCM8 | MCM8-MCM9 complex | MCM9 | MCMBP | MCMDC2 | MCOLN1 | MCOLN2 | MCOLN3 | MCPH1